34. Endocrine Care

CHAPTER 34. Endocrine Care

Laura Currie


OBJECTIVES
At the conclusion of this chapter, the reader will be able to:


1. Describe the basic function of the endocrine system including the hormones produced by the thyroid, parathyroid, pituitary, and adrenal glands.


2. Identify the signs, symptoms, and diagnostic testing used to assess endocrine gland function.


3. Identify the surgical procedure and perioperative considerations for the patient with hyperthyroidism, hypothyroidism, pheochromocytoma, hypersecretion and hyposecretion of the pituitary and adrenal glands.


4. Identify the postanesthesia plan of care for the patient having subtotal thyroidectomy, bilateral adrenalectomy, hypophysectomy, and parathyroidectomy.


5. Discuss the postanesthesia considerations of the patient with endocrine dysfunctions: thyrotoxicosis, hypercalcemia, Cushing’s syndrome, Addison’s disease, diabetes insipidus, syndrome of inappropriate antidiuretic hormone.


6. Discuss the postanesthesia care of the diabetic patient and diabetic emergencies: hypoglycemia, diabetic ketoacidosis, and hyperglycemic hyperosmolar syndrome.





I. THYROID GLAND


A. Anatomy and physiology (Figure 34-1)


1. Location


a. Sits in anterior portion of the neck


b. Right lobe below the larynx


c. Left lobe beside the trachea


d. Middle portion called the isthmus lies at the base of the neck between second and fourth tracheal rings.


2. Blood supply from external carotid arteries


3. Nerve supply from cervical sympathetic trunk


4. Functions of thyroid gland


a. Regulates energy, metabolism and growth, and development


(1) Hormone production from the hypothalamic-pituitary-thyroid axis


(a) Hypothalamus secretes thyrotropin-releasing hormone (TRH)→stimulates the anterior pituitary to secrete thyroid-stimulating hormone (TSH)→increases the production of the thyroid hormones (THs) thyroxine (T 4) and triiodothyronine (T 3) and the uptake of iodide


(2) Negative feedback loop (Figure 34-2)


(a) Hypothalamus secretes TRH to regulate the synthesis and release of TSH.


(b) When TH levels decrease, TSH and TRH levels increase.


(c) Conversely, if TH levels increase, TSH and TRH levels decrease.









B9781416051930000340/gr2.jpg is missing
FIGURE 34-2 ▪
Hypothalamus-pituitary-thyroid axis.




b. T 3 has a short half-life, and T 4 has a half-life of 5 to 7 days.


c. Peripheral tissue converts T 4 to T 3.


d. T 3 considered the true tissue TH


e. T 4 considered a plasma prohormone



B. Comparison of hyperthyroid and hypothyroid conditions (Table 34-1)






































TABLE 34-1 Comparison of Hyperthyroid and Hypothyroid Conditions
T3 , Triiodothyronine; T4, thyroxine; TSH, thyroid-stimulating hormone.

Hyperthyroid Hypothyroid
Description Excessive secretion of thyroid hormones Insufficient secretion of thyroid hormones
Causes


Multinodular, toxic, diffuse enlargement (goiter)—Graves’ disease


Malignancy


Thyroiditis


Viral, autoimmune


Excessive iodine intake


Amiodarone toxicity secondary to high concentrations of iodine; inhibits the conversion of T 4 to T 3



Chronic thyroiditis—progressively destroys thyroid function (Hashimoto’s thyroiditis)


Autoimmune diseases


Iodine deficiency


Surgical removal of thyroid


Secondary dysfunction related to pituitary problems


Tertiary dysfunction related to hypothalamus problems
Signs and symptoms


Cardiopulmonary


Hypertension


Tachycardia or new atrial fibrillation


Low blood pressure—fluid loss


Potential heart failure


Tachypnea


Eyes/Ears/Nose/Throat


Exophthalmos


Enlarged thyroid /goiter


Hoarseness/difficulty swallowing


Gastrointestinal


Weight loss


Increased peristalsis


Diarrhea and abdominal pain


Musculoskeletal


Body thinness


Muscle atrophy and weakness


Skin


Diaphoresis


Fine, silky, thin hair


Hyperpigmentation


Nervous System


Hyperactive emotional state


Heat intolerance


Insomnia


Genitourinary


Menstrual cycle changes


Infertility



Cardiopulmonary


Bradycardia


Decreased cardiac output


High blood pressure—fluid retention


Peripheral vasoconstriction


Increased cholesterol levels


Eyes/Ears/Nose/Throat


Puffy eyes, enlarged tongue


Goiter


Hoarseness/difficulty swallowing


Gastrointestinal


Weight gain


Constipation


Musculoskeletal


Muscle weakness


Joint pain


Skin


Dry


Alopecia


Myxedema (late)


Nervous System


Fatigue, inability to concentrate


Miscellaneous


Cold intolerance


Genitourinary


Heavy menstrual bleeding


Infertility
Diagnostic tests


TSH decreased


T 3 increased


Free T 4 increased


Thyroid scan: radioactive iodine uptake


Ultrasonography: identification of tumor type


Fine-needle aspiration



TSH increased


T 3 decreased


Free T 4 decreased
Operative procedures to correct condition


Purpose: remove tracheal/esophageal obstructions or malignancy


Subtotal thyroid lobectomy (partial lobe)


Thyroid lobectomy (total lobe)


Total thyroidectomy (removal of entire gland)



No specific surgery


Comorbid condition
Preoperative objectives


Promote a euthyroid state by:


Regulating antithyroid drugs


Controlling hyperdynamic cardiac status


Educate patient and family related to type of surgery/procedure, incision site, drains, and pain.


Thyroid surgery–specific head and neck support when turning



Promote a euthyroid state by:


Regulating thyroid replacement


Educate patient and family related to type of surgery/procedure, incision site, drains, and pain.
Anesthesia concerns


Corneal drying or abrasions


Considerations of agents based on euthyroid state


Stability of cardiac status


Airway status


Oxygen requirements increased with hypermetabolic state and increased temperature


Vocal cord visualization for injury to recurrent laryngeal nerves



Predisposition to hypothermia, cardiac failure, and delayed gastric emptying


Metabolism of medications may be delayed.


Adrenal insufficiency: may consider glucocorticoids to correct insufficiency


Neuromuscular weakness may affect weaning.


Potential difficult intubation secondary to predisposition for an enlarged tongue


C. Medical therapy: goal is to promote a euthyroid state.


1. Hyperthyroid conditions


a. Inhibition of TH synthesis


(1) Propylthiouracil: 600- to 1000-mg loading dose followed by 200 to 250 mg every 4 hours


(a) Blocks conversion of T 4 and T 3


(b) Administered at least 6 to 12 weeks preoperatively to achieve euthyroid state


(c) Avoid acetylsalicylic acid because it displaces T 3 from protein binding.


(2) Methimazole: 60 to 120 mg/day in divided doses


(a) Blocks uptake of iodine


(b) Administered 6 to 12 weeks preoperatively to achieve euthyroid state


b. Inhibition of TH release


(1) Saturated solution of potassium iodide


(a) 50 mg iodine per drop: 1 to 2 drops three times per day


(b) Iodide blocks T 4 release from the thyroid gland.


(c) Acute management


(2) Lugol’s solution (5% iodine, 10% potassium solution)


(a) 8 mg iodine per drop


(b) Acute management: 4 to 8 drops Lugol’s solution or saturated solution of sodium iodide every 6 to 8 hours; administer at least 2 to 3 hours after initial dosing of inhibitors of TH synthesis.


(3) Lithium carbonate: 300 mg every 6 hours


c. Inhibition of sympathetic nervous system innervation


(1) Beta-blockers first choice


(a) Propanolol: 0.5 to 1 mg intravenously (IV) every 15 minutes as needed, as loading dose until onset of action of oral propranolol (60-80 mg every 4 hours)


(b) Esmolol: loading dose of 250 to 500 mcg/kg followed by infusion of 50 to 100 mcg/kg per minute


(2) Calcium channel blockers if unable to tolerate beta-blockers


d. Prevent peripheral conversion of T 4 to T 3 during acute thyrotoxic storm.


(1) Hydrocortisone: 300 mg initially, followed by 100 mg every 8 hours IV


(2) Dexamethasone: 2 mg IV every 6 hours


(3) Prednisone: 40 mg/day—amiodarone-induced thyrotoxicosis


2. Hypothyroid conditions


a. Replace hormone


(1) Chronic—levothyroxine: 1 to 1.5 mcg/kg per day orally initially; adjust as needed every 6 weeks until TSH in normal range; average dosage 1.6 to 1.8 mcg/kg per day (1.3 mcg/kg per day in the elderly)


(2) Acute—myxedema coma: initial dosage 200 to 500 mcg IV daily; reduce dosage to 50 to 100 mcg IV daily until patient is able to take medication orally.


D. Postanesthesia nursing plan of care (Boxes 34-1 and 34-2)

BOX 34-1
DIFFERENCES BETWEEN THYROTOXIC CRISIS AND MALIGNANT HYPERTHERMIA





















Thyrotoxic Crisis Malignant Hyperthermia
Trigger Increase in circulating thyroid hormones due to physiological stress Exposure to anesthetic agents such as succinylcholine and/or volatile inhalation agents
Acute signs and symptoms


Hyperthermia


Tachycardia


Hypercarbia


No muscle rigidity



Hyperthermia


Tachycardia


Hypercarbia


Muscle rigidity
Treatment Beta Blockers Steroids Dantrolene sodium

BOX 34-2
POSTANESTHESIA NURSING PLAN OF CARE: THYROID SURGERY/CONDITIONS




Managing Hyperthyroid Conditions After Thyroid Surgery



Nursing Diagnosis





▪ Ineffective airway clearance related to edema of surgical area


▪ Impaired gas exchange related to increased metabolic demands


▪ Alteration in tissue perfusion related to hyperdynamic metabolic state


▪ Ineffective thermoregulation related to hyperdynamic metabolic state


Interventions



Airway Management





▪ Assess for signs of distress resulting from edema of the glottis or hematoma formation: dyspnea, cyanosis, stridor, retraction of neck muscles, tracheal deviation.


▪ Manage secretions to decrease strain on incision line caused by coughing.


▪ Manage oxygenation secondary to increased metabolic demands with supplemental humidified oxygen.


▪ Manage ventilation by monitoring rate, depth, and acid-base balance (arterial blood gases).


Cardiac Status





▪ Assess cardiac status secondary to hypermetabolic state, activation of the sympathetic nervous systems from the stress of surgery.


Wound Management





▪ Assess incision line for wound hemorrhaging (early complication) and report immediately.


▪ Monitor drainage devices if used.


▪ Assess laryngeal nerve damage by quality of vocalization and ability to swallow.


Positioning





▪ Maintain proper positioning after surgery.



30 ° or higher head positioning


Proper neck support by avoiding extreme head flexion or extension


General





▪ Monitor for tetany and hypocalcemia if combined with removal of parathyroid glands.


Laryngeal spasm, tingling in toes, fingers, mouth


Positive Chvostek’s sign: twitching of facial muscles if cheek is tapped over facial nerve


Positive Trousseau’s sign: carpopedal spasm if circulation in arm is impeded with blood pressure cuff


▪ Monitor for thyrotoxic crisis (storm) versus malignant hyperthermia (see Box 34-1).


Managing Hypothyroid Conditions After Surgery



Nursing Diagnosis





▪ Impaired gas exchange related to decreased metabolism of medications


▪ Ineffective airway clearance related to neurological weakness


▪ Ineffective thermoregulation related to decreased metabolic state


▪ Alteration in tissue perfusion related to decreased metabolic state


Interventions



Airway Management





▪ Assess for signs of distress related to neurological weakness, sensitivity to medications, and predisposition for an enlarged tongue.


▪ Manage oxygenation secondary to decreased metabolism of medications.


▪ Manage ventilation by monitoring rate, depth, and acid-base balance (arterial blood gases).


Cardiac Status





▪ Assess for signs and symptoms of low cardiac output/heart failure.


▪ Assess for bradycardia.


Thermoregulation





▪ Monitor temperature secondary to predisposition to hypothermia.


II. PARATHYROID GLANDS (see Figure 34-1)


A. Anatomy and physiology


1. Consists of four small ovoid masses of tissue lying behind the thyroid gland


2. Parathyroid hormone (PTH) secreted from parathyroid glands


a. PTH and vitamin D responsible for the regulation of calcium and phosphorous


b. Serum calcium maintained by:


(1) Regulating bone turnover


(2) Absorption of calcium from the gut (with vitamin D)


(3) Release of calcium in the urine


c. PTH release inhibited by rising serum calcium level


d. PTH release dependent on normal serum magnesium levels


B. Hyperparathyroid disease (Table 34-2)











B9781416051930000340/gr1a.jpg is missing

B9781416051930000340/gr1b.jpg is missing
FIGURE 34-1 ▪
Anatomy of thyroid and parathyroid gland.

(From Thibodeau GA, Patton KT: Anatomy & physiology, ed 6, St Louis, 2007, Mosby.)
























































TABLE 34-2 Hyperparathyroid Disease
H2, Histamine type 2; PTH, parathyroid hormone.
*Normal values vary with laboratories.

Primary Hyperparathyroidism Secondary Hyperparathyroidism
Description Excessive secretion of PTH, resulting in hypercalcemia Hyperplasia of the parathyroid secondary to the dysfunction of another organ or secondary to another condition
Causes


Adenomas (single or multiple gland) most common


Hyperplasia of one or more glands


Malignancies (rare)


Previous head or neck radiation



Vitamin D conditions (deficiency, malabsorption, metabolism, osteomalacia [i.e., rickets])


Calcium disorders


Phosphate disorders


Chronic renal failure
Signs and symptoms Result from hypercalcemia:


Cardiopulmonary


Hypertension


Dysrhythmias


Nervous System


Irritability


Somnolence


Lethargy


Genitourinary


Renal calculi


Polyuria


Musculoskeletal


Osteopenia and osteoporosis


Muscle weakness


Joint or back pain


Gastrointestinal


Abdominal pain


Constipation


Nausea


Risk for gastric ulcers and pancreatitis
LABORATORY TESTS*
PTH


Normal: 10–65 mg/mL


Hyperparathyroid conditions: Elevated
Ionized calcium


Normal: 4.5–5.6 mg/dL


Hyperparathyroid conditions: Elevated
Calcium


Normal: 9.0–10.5 mg/dL


Hyperparathyroid conditions: Elevated
Phosphorus


Normal: 2.5–4.5 mg/dL


Hyperparathyroid conditions: Decreased
Operative procedures to correct condition


Surgical removal of parathyroid


Total parathyroidectomy: removal of all glands


Partial parathyroidectomy: removal of up to 3.5 of 4 glands


Minimally invasive parathyroidectomy
Preoperative objectives


Treat hypercalcemia and correct associated conditions.


Saline hydration and furosemide administration for rapid correction


Calcitonin


Mithramycin for thrombocytopenia and renal problems


Prednisone


Dysrhythmia management


Educate patient and family related to type of surgery/procedure, incision site, drains, and pain.


Parathyroid surgery–specific head and neck support when turning
Anesthesia concerns


Intravascular volume changes


Postoperative airway obstruction related to recurrent laryngeal nerve injury or bleeding


Renal, cardiac, and nervous system abnormalities


Consider prophylaxis with H 2 receptor blockers.


C. Postanesthesia nursing plan of care (Box 34-3)

BOX 34-3
POSTANESTHESIA NURSING PLAN OF CARE: PARATHYROID SURGERY




Nursing Diagnosis





▪ Ineffective airway clearance related to edema of surgical area


▪ Impaired gas exchange related to postoperative bleeding or swelling or inability to move secretions


▪ Alteration in fluid and electrolyte balance secondary to total or partial removal of parathyroid gland(s)


▪ Alteration in tissue perfusion related to cardiac dysrhythmias


▪ Altered sensory perception related to postoperative hypocalcemia


Interventions



Airway Management





▪ Assess for signs of distress resulting from edema of the glottis or hematoma formation: dyspnea, cyanosis, stridor, retraction of neck muscles, tracheal deviation.


▪ Manage secretions to decrease strain on incision line caused by coughing.


▪ Manage oxygenation secondary to increased metabolic demands with supplemental humidified oxygen.


▪ Manage ventilation by monitoring rate, depth, and acid-base balance (arterial blood gases).


Cardiac Status





▪ Assess cardiac status secondary to hypocalcemia.


Wound Management





▪ Assess incision line for wound hemorrhaging or hematoma and report immediately.


▪ Assess laryngeal nerve damage by quality of vocalization and ability to swallow.


▪ Maintain proper positioning after surgery.


30 ° or higher head positioning


Proper neck support by avoiding extreme head flexion or extension


General





▪ Monitor for tetany and hypocalcemia with removal of parathyroid glands (immediate to 72 hours postoperatively).


Laryngeal spasm, tingling in toes, fingers, mouth

May 13, 2017 | Posted by in NURSING | Comments Off on 34. Endocrine Care

Full access? Get Clinical Tree

Get Clinical Tree app for offline access